gabapentin has been researched along with Cacosmia in 2 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garcia, JAP | 2 |
| Miller, E | 2 |
| Norwood, TG | 2 |
| Dorin, NA | 2 |
| Grayson, J | 2 |
| Woodworth, B | 2 |
| Cho, DY | 2 |
| Aksan, F | 1 |
| Nelson, EA | 1 |
| Swedish, KA | 1 |
2 other studies available for gabapentin and Cacosmia
| Article | Year |
|---|---|
Gabapentin improves parosmia after COVID-19 infection.
Topics: COVID-19; Gabapentin; Humans; Olfaction Disorders; Smell | 2023 |
Gabapentin improves parosmia after COVID-19 infection.
Topics: COVID-19; Gabapentin; Humans; Olfaction Disorders; Smell | 2023 |
Gabapentin improves parosmia after COVID-19 infection.
Topics: COVID-19; Gabapentin; Humans; Olfaction Disorders; Smell | 2023 |
Gabapentin improves parosmia after COVID-19 infection.
Topics: COVID-19; Gabapentin; Humans; Olfaction Disorders; Smell | 2023 |
A COVID-19 patient with intense burning pain.
Topics: Acetaminophen; Analgesics; Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome; Back Pain; | 2020 |